Workflow
Enphys Acquisition (NFYS)
icon
Search documents
Enphys Acquisition (NFYS) - 2024 Q1 - Quarterly Report
2024-05-17 20:59
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorpo ...
Enphys Acquisition (NFYS) - 2023 Q4 - Annual Report
2024-04-16 20:01
If, before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy or insolvency petition or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced. If, before distributing the proceeds in the trust account to ...
Enphys Acquisition (NFYS) - 2023 Q3 - Quarterly Report
2023-11-20 21:44
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of inc ...
Enphys Acquisition (NFYS) - 2023 Q2 - Quarterly Report
2023-08-18 21:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorpor ...
Enphys Acquisition (NFYS) - 2023 Q1 - Quarterly Report
2023-05-22 21:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorpo ...
Enphys Acquisition (NFYS) - 2022 Q4 - Annual Report
2023-04-13 20:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) | Cayman Islands | 001-39706 | 87-2010879 | | --- | --- | --- | | (State or other jurisdiction ...
Enphys Acquisition (NFYS) - 2022 Q3 - Quarterly Report
2022-11-21 23:45
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 216 East ...
Enphys Acquisition (NFYS) - 2022 Q2 - Quarterly Report
2022-08-15 21:21
Financial Performance - For the three months ended June 30, 2022, the company reported a net income of $1,218,156, which included general and administrative expenses of $393,858 and net gains from derivative liabilities and marketable securities of $1,611,014[116] - For the six months ended June 30, 2022, the company achieved a net income of $6,875,640, with general and administrative expenses totaling $580,730 and net gains from derivative liabilities and marketable securities amounting to $7,456,370[117] Cash and Working Capital - As of June 30, 2022, the company had cash of $605,283 and working capital of $445,033[118] - Management believes that the current working capital and borrowing capacity will be sufficient to meet needs through the completion of a business combination or one year from the filing date[120] - The company has no outstanding amounts under any working capital loans as of June 30, 2022[119] Business Operations - The company has not generated any operating revenues to date and will only do so after completing its initial business combination[114] - The company may need to raise additional funds if the costs of identifying a target business exceed current estimates[121] Public Company Costs - The company expects to incur significantly increased expenses due to being a public company, including legal, financial reporting, and compliance costs[114] COVID-19 Impact - Management continues to evaluate the impact of the COVID-19 pandemic, but the specific impact remains uncertain as of the date of the financial statements[122] Underwriting Activities - The underwriters exercised an over-allotment option on October 8, 2021, purchasing an additional 4,500,000 Units at an offering price of $10.00 per Unit, generating gross proceeds of $45.0 million[125]
Enphys Acquisition (NFYS) - 2022 Q1 - Quarterly Report
2022-05-20 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporation or organization) 216 East 45th Street 13th Floor New York, NY 10017 (Address of principal exec ...
Enphys Acquisition (NFYS) - 2021 Q4 - Annual Report
2022-04-22 21:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) | Cayman Islands | 001-39706 | 87-2010879 | | --- | --- | --- | | (State or other jurisdiction ...